Slingshot Insights | Blph Overview

BLPH Overview

Upcoming Projects (BLPH)

Don’t see a project related to the company you care about? Create your own!

Expired Projects (BLPH)

What to Expect from Phase 2 Data Evaluating Bellerophon's (BLPH) INOpulse Delivery Device for Pulmonary Hypertension Associated with COPD and Idiopathic Pulmonary Fibrosis Due in Q1 2017
Ticker: BLPH
Execute By: Jan 31, 2017

Upcoming & Overdue Catalysts (BLPH)

Don’t see a catalyst related to the company you care about? Create your own!

Occurred Catalysts (BLPH)

Additional cohort 1 data for Bellerophon's(BLPH) INOpulse delivery device in Pulmonary Hypertension associated with Interstitial Lung Disease (PH-ILD) due to be presented at ATS May 20, 2019
Ticker: BLPH
Occurred on: May 21, 2019
Phase 2 data of INOpulse delivery device for Pulmonary Hypertension associated with COPD and Idiopathic Pulmonary Fibrosis expected Q1 2017
Ticker: BLPH
Occurred on: May 01, 2017
Bellerophon Therapeutics (BLPH) Prices $12MM Equity Offering of Class A Units
Ticker: BLPH
Occurred on: Nov 23, 2016
Bellerophon Receives Approval to Commence Phase 2 Trial in PH-COPD
Ticker: BLPH
Occurred on: Jul 25, 2016
Bellerophon Therapeutics Announces Enrollment of the First Patient in the INOvation-1 Phase 3 Clinical Trial for Pulmonary Arterial Hypertension (PAH)
Ticker: BLPH
Occurred on: Jun 16, 2016
Bellerophon Therapeutics Announces Positive Data From the Final Analysis of the Phase 2 Long-Term Extension Study of INOpulse for Treatment of Pulmonary Arterial Hypertension
Ticker: BLPH
Occurred on: Feb 09, 2016

Strategic Initiatives (BLPH)

Don’t see a strategic initiative related to the company you care about? Create your own!